THE SCAN CAME BACK EMPTY.
Two doses of a new immunotherapy cleared a child's liver cancer.
Researchers at Texas Children's, Baylor College of Medicine and Seattle Children's reported in the New England Journal of Medicine that a child with hepatoblastoma had complete regression of disease after a novel immunotherapy given as part of the CARE study.